SGTRX
Price
$72.48
Change
-$0.01 (-0.01%)
Updated
Oct 17 closing price
SLMCX
Price
$132.73
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
Ad is loading...

SGTRX vs SLMCX

Header iconSGTRX vs SLMCX Comparison
Open Charts SGTRX vs SLMCXBanner chart's image
Columbia Seligman Global Tech R
Price$72.48
Change-$0.01 (-0.01%)
VolumeN/A
CapitalizationN/A
Columbia Seligman Tech & Info A
Price$132.73
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
SGTRX vs SLMCX Comparison Chart
Loading...
VS
SGTRX vs. SLMCX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGTRX is a Buy and SLMCX is a Buy.

FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 13.6B vs. SGTRX (2.45B). SGTRX (0.00) and SLMCX (0.00) have matching dividends . SGTRX was incepted earlier than SLMCX: SGTRX (21 years) vs SLMCX (41 years). SGTRX is a more actively managed with annual turnover of: 22.00 vs. SLMCX (13.00). SGTRX has a lower initial minimum investment than SLMCX: SGTRX (0) vs SLMCX (2000). SLMCX annual gain was more profitable for investors over the last year : 27.03 vs. SGTRX (25.50). SGTRX return over 5 years is better than : 76.37 vs. SLMCX (70.82).
SGTRXSLMCXSGTRX / SLMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years41 years-
Gain YTD18.70018.721100%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.45B13.6B18%
Annual Yield % from dividends0.000.00-
Returns for 1 year25.5027.0394%
Returns for 3 years6.073.97153%
Returns for 5 years76.3770.82108%
Returns for 10 years169.78146.16116%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RUNTX29.410.38
+1.31%
Russell Inv US Small Cap Equity M
SLVIX37.460.31
+0.83%
Columbia Select Large Cap Value Inst2
RRFDX38.520.28
+0.73%
T. Rowe Price Equity Income R
GFVAX16.73N/A
N/A
Goldman Sachs Focused Value A
NALFX69.57N/A
N/A
New Alternatives A